Detailed Information on Publication Record
2020
Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA.
ŠUMNÍK, Zdeněk, Jitřenka VENHÁČOVÁ, Jaroslav ŠKVOR, Renata POMAHAČOVÁ, Petra KONEČNÁ et. al.Basic information
Original name
Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA.
Name in Czech
Zvýšení kontroly diabetu u českých dětí 5 let po vytvoření populačního registru diabetu: ČENDA
Authors
ŠUMNÍK, Zdeněk, Jitřenka VENHÁČOVÁ, Jaroslav ŠKVOR, Renata POMAHAČOVÁ, Petra KONEČNÁ, David NEUMANN, jiří VOSÁHLO, jiří STRNADEL, Jindřich ČÍŽEK, Barbora OBERMANNOVÁ, Lenka PETRUŽELKOVÁ, Štěpánka PRŮHOVÁ, Markéta PAVLÍKOVÁ, Ondřej CINEK and Jana VYŽRÁLKOVÁ
Edition
Pediatric Diabetes, Spojené státy americké, Wiley, 2020, 1399-5448
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30209 Paediatrics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.866
Organization unit
Faculty of Medicine
UT WoS
000490350900001
Keywords (in Czech)
diabetes; děti
Keywords in English
diabetes; children
Změněno: 5/6/2020 14:28, Mgr. Tereza Miškechová
V originále
OBJECTIVES: The Czech National Childhood Diabetes Register (ČENDA) is a web-based nationwide database that collects treatment and outcome data in children and adolescents with diabetes. Here, we present data from the first 5 years of ČENDA (2013-2017). METHODS: Data include characteristics of disease onset and annual summaries of key clinical care parameters from every patient treated by participating pediatric diabetes outpatient clinics. RESULTS: The database contains data of 4361 children (aged 0-19 years) from 52 centers (85% of all Czech pediatric patients). Of these, 94% had type 1 diabetes (T1D), 4.5% had genetically proven monogenic or secondary, and 1.5% had type 2 diabetes. In children with T1D, median glycated hemoglobin (HbA1c) decreased throughout the observed period from 66.3 to 61.0 mmol/mol (P < .0001, 95% confidence interval [CI] for change -5.6 to -4 mmol/mol). Consequently, the proportion of children reaching the target therapeutic goal of 58.5 mmol/mol increased from 28% in 2013 to 40% in 2017. The proportion of children treated with insulin pumps (CSII) remained stable over the observed period (25%). In a subanalysis of 1602 patients (long-standing T1D diagnosed before 2011), the main predictors associated with lower HbA1c were treatment with CSII, male sex and care provided at a large diabetes center (>100 patients). CONCLUSIONS: A significant continuous decrease in HbA1c was observed in Czech children over the past 5 years. As this improvement was not accompanied by appreciable changes in the mode of therapy, we assume that the establishment of our nationwide register has itself constituted a stimulus towards improvement in the care process.
In Czech
Autoři popisují výsledky kontroly dětí s diabetes mellitus v České republice po ustavení tzv. registru ČENDA.